Clinton Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-8,389
Closed -$236K 795
2017
Q1
$236K Sell
8,389
-265
-3% -$7.48K 0.01% 831
2016
Q4
$254K Sell
8,654
-1,713
-17% -$46.7K 0.01% 726
2016
Q3
$282K Sell
10,367
-9,920
-49% -$224K 0.01% 780
2016
Q2
$379K Buy
+20,287
New +$423K 0.02% 699

Other funds holding PAHC

Clinton Group's PAHC Position: Q2 2017 in Review

Clinton Group sold out of Phibro Animal Health (PAHC) in Q2 2017, closing a stake of 8,389 shares — an estimated $236K sold.

Clinton Group first reported a position in PAHC in Q2 2016 and held it in 4 quarters. The position peaked at $379K in Q2 2016. 168 funds tracked by Wall St. Rank hold PAHC as of Q2 2017.

  • Clinton Group reported no remaining Phibro Animal Health position as of Q2 2017 after selling out during the quarter.
  • Clinton Group sold 8,389 Phibro Animal Health shares in Q2 2017, an estimated $236K.
  • Clinton Group first reported a position in Phibro Animal Health in Q2 2016 and held it in 4 quarters.
  • Clinton Group's Phibro Animal Health position peaked at $379K in Q2 2016.
  • 168 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2017.

Based on Clinton Group's 13F filing for Q2 2017, filed 14 Aug 2017.